Exact Sciences Quarterly Income Statements Chart
Quarterly
|
Annual
Exact Sciences Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 | 2002-12-31 | 2002-09-30 | 2002-06-30 | 2002-03-31 | 2002-02-10 | 2001-12-31 | 2001-09-30 | 2001-06-30 | 2000-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 811,085,000 | 706,785,000 | 713,424,000 | 708,655,000 | 699,264,000 | 637,524,000 | 646,885,000 | 628,338,000 | 622,093,000 | 602,450,000 | 552,995,000 | 523,073,000 | 521,640,000 | 486,571,000 | 473,812,000 | 456,379,000 | 434,819,000 | 402,077,000 | 466,339,000 | 408,363,000 | 268,868,000 | 347,821,000 | 295,575,000 | 218,805,000 | 199,870,000 | 162,043,000 | 406,000 | 408,000 | 122,175.25 | 409,479 | 39,956 | 39,266 | 39,956 | 3,272.25 | 13,089 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | 15.99% | 10.86% | 10.29% | 12.78% | 12.41% | 5.82% | 16.98% | 20.12% | 19.26% | 23.82% | 16.71% | 14.61% | 19.97% | 21.01% | 1.60% | 11.76% | 61.72% | 15.60% | 57.77% | 86.63% | 34.52% | 114.65% | 916.12% | 939.07% | 205.77% | 12413.68% | 205.26% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | 14.76% | -0.93% | 0.67% | 1.34% | 9.68% | -1.45% | 2.95% | 1.00% | 3.26% | 8.94% | 5.72% | 0.27% | 7.21% | 2.69% | 3.82% | 4.96% | 8.14% | -13.78% | 14.20% | 51.88% | -22.70% | 17.68% | 35.09% | 9.47% | 23.34% | -0.49% | 233.95% | -70.16% | 924.82% | 1.76% | -1.73% | 1121.06% | -75.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of sales | 248,632,000 | 206,238,000 | 284,131,000 | 196,070,000 | 189,848,000 | 170,101,000 | 171,865,000 | 168,526,000 | 156,991,000 | 156,866,000 | 147,152,000 | 147,937,000 | 144,600,000 | 134,705,000 | 119,058,000 | 115,738,000 | 113,968,000 | 109,993,000 | 99,765,000 | 95,061,000 | 77,892,000 | 81,606,000 | 69,143,000 | 52,759,000 | 51,563,000 | 43,252,000 | 38,160,000 | 30,020,000 | 26,888,000 | 22,914,000 | 23,495,000 | 20,729,000 | 17,991,000 | 16,981,000 | 13,865,000 | 12,174,000 | 10,097,000 | 9,059,000 | 7,667,000 | 7,528,000 | 5,094,000 | 4,212,000 | 3,401,000 | 924,000 | ||||||||||||||||||||||||||||||||||||||||||||||
gross profit | 562,453,000 | 500,547,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,033,000 | 1,036,000 | 1,034,000 | 1,350,000 | 1,308,000 | 1,293,000 | 1,251,000 | 1,250,000 | 1,000,000 | 50,000 | 67,000 | 1,114,000 | 1,168,000 | 1,154,000 | 1,053,000 | 1,128,000 | 606,000 | -2,549,316 | 863,000 | 491,000 | 1,199,000 | 1,038,000 | 1,162,000 | 1,145,000 | 905,000 | 405,000 | 120,566.5 | 405,321 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | 0.00% | 0.19% | -23.26% | -21.02% | -19.88% | -17.35% | 8.00% | 30.80% | 2400.00% | 1392.54% | -95.67% | -93.64% | -1.24% | 92.74% | -145.27% | 22.02% | 129.74% | -49.46% | -345.60% | -25.73% | -57.12% | 32.49% | 186.91% | 849.68% | 123.28% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | 12.37% | 0.00% | 0.00% | 0.29% | -0.29% | 0.19% | -23.41% | 3.21% | 1.16% | 3.36% | 0.08% | 25.00% | -25.37% | -93.99% | -4.62% | 1.21% | 9.59% | -6.65% | 86.14% | -123.77% | -395.40% | 75.76% | -59.05% | 15.51% | -10.67% | 1.48% | 26.52% | 235.91% | -70.25% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin % | 69.35% | 70.82% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 99.26% | 98.68% | 98.98% | 0% | 0% | 0% | 0% | 0% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
research and development | 108,901,000 | 105,310,000 | 99,617,000 | 100,101,000 | 120,884,000 | 110,608,000 | 114,922,000 | 111,446,000 | 104,095,000 | 95,419,000 | 94,274,000 | 90,813,000 | 106,083,000 | 102,248,000 | 88,488,000 | 75,356,000 | 106,235,000 | 115,567,000 | 446,399,000 | 31,471,000 | 32,673,000 | 43,509,000 | 42,530,000 | 34,945,000 | 30,203,000 | 32,016,000 | 20,932,000 | 17,631,000 | 14,712,000 | 14,935,000 | 12,675,000 | 11,725,000 | 9,737,000 | 8,002,000 | 7,082,000 | 7,625,000 | 8,640,000 | 10,126,000 | 9,365,000 | 9,863,000 | 8,115,000 | 6,571,000 | 4,992,000 | 9,073,000 | 7,174,000 | 7,430,000 | 6,982,000 | 6,457,000 | 7,526,000 | 10,491,000 | 12,202,000 | 8,999,000 | 6,110,000 | 5,197,000 | 2,989,000 | 2,635,000 | 2,123,000 | 1,795,000 | 837,000 | 2,015,000 | 108,000 | 577,000 | 528,000 | 859,000 | 1,009,000 | 1,332,000 | 1,277,000 | 1,152,000 | 1,705,000 | 1,918,000 | 1,960,000 | -6,085,157 | 1,937,000 | 1,875,000 | 2,281,000 | 2,518,000 | 2,640,000 | 3,134,000 | 4,312,000 | 4,592,000 | 5,013,000 | 3,809,827 | 5,130,706 | 5,065,822 | 5,042,780 | 5,065,822 | 2,231,847.5 | 3,535,013 | 2,849,562 | |
sales and marketing | 247,118,000 | 264,310,000 | 321,837,000 | 194,653,000 | 185,270,000 | 192,365,000 | 190,477,000 | 173,159,000 | 176,490,000 | 186,964,000 | 210,211,000 | 187,697,000 | 215,922,000 | 232,181,000 | 284,304,000 | 196,617,000 | 194,827,000 | 186,141,000 | 166,827,000 | 136,481,000 | 118,862,000 | 167,749,000 | 119,851,000 | 86,196,000 | 88,190,000 | 90,939,000 | 76,773,000 | 64,836,000 | 54,431,000 | 53,408,000 | 40,627,000 | 37,768,000 | 36,728,000 | 38,801,000 | 30,506,000 | 26,308,000 | 30,301,000 | 25,711,000 | 21,944,000 | 23,079,000 | 20,593,000 | 16,524,000 | 15,069,000 | 13,217,000 | 6,166,000 | 4,456,000 | 1,615,000 | 3,302,000 | 1,759,000 | 1,006,000 | 1,331,000 | 594,000 | 815,000 | 651,000 | 297,000 | 315,000 | 330,000 | 109,000 | 12,000 | 40,000 | 385,000 | 510,000 | 495,000 | 624,000 | 1,051,000 | 1,272,000 | 1,486,000 | -4,403,382 | 1,191,000 | 1,619,000 | 1,599,000 | |||||||||||||||||||
general and administrative | 208,582,000 | 220,686,000 | 119,651,000 | 217,201,000 | 201,856,000 | 243,117,000 | 220,551,000 | 217,393,000 | 237,965,000 | 217,295,000 | 193,894,000 | 191,968,000 | 181,672,000 | 169,770,000 | 179,365,000 | 186,541,000 | 167,629,000 | 267,727,000 | 145,451,000 | 115,589,000 | 106,685,000 | 113,991,000 | 144,124,000 | 80,565,000 | 63,734,000 | 64,030,000 | 56,432,000 | 46,729,000 | 39,565,000 | 35,567,000 | 33,598,000 | 30,763,000 | 24,609,000 | 20,070,000 | 21,498,000 | 20,292,000 | 17,284,000 | 17,824,000 | 15,864,000 | 15,432,000 | 13,683,000 | 12,971,000 | 10,625,000 | 8,994,000 | 6,230,000 | 4,586,000 | 3,686,000 | 3,628,000 | 2,648,000 | 2,547,000 | 2,393,000 | 2,145,000 | 1,951,000 | 1,830,000 | 2,150,000 | 1,796,000 | 1,339,000 | 1,512,000 | 1,478,000 | 1,638,000 | 4,768,000 | 1,271,000 | 1,495,000 | 1,835,000 | 2,290,000 | 1,337,000 | 1,542,000 | 1,431,000 | 1,700,000 | 1,497,000 | 1,641,000 | -3,768,274 | 1,395,000 | 1,157,000 | 1,221,000 | 427,026 | 427,026 | 573,390.25 | 654,085 | 2,606,416 | ||||||||||
impairment of long-lived and indefinite-lived assets | 6,251,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total operating expenses | 564,601,000 | 596,557,000 | 752,193,000 | 751,158,000 | 729,321,000 | 743,948,000 | 721,126,000 | 693,516,000 | 699,022,000 | 679,541,000 | 671,877,000 | 647,887,000 | 681,224,000 | 663,558,000 | 695,262,000 | 618,402,000 | 606,483,000 | 702,618,000 | 881,641,000 | 611,698,000 | 359,542,000 | 430,194,000 | 539,257,000 | 201,706,000 | 182,127,000 | 186,985,000 | 154,137,000 | 129,196,000 | 108,708,000 | 103,910,000 | 86,900,000 | 80,256,000 | 71,074,000 | 66,873,000 | 59,086,000 | 54,225,000 | 56,225,000 | 53,661,000 | 47,173,000 | 48,374,000 | 42,391,000 | 36,066,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
other operating income | 2,568,000 | 3,100,000 | 3,800,000 | -268,000 | 6,400,000 | 72,027,000 | -13,244,000 | 23,665,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from operations | -2,148,000 | -96,010,000 | -876,351,000 | -39,403,000 | -26,257,000 | -106,692,000 | -67,841,000 | 6,849,000 | -76,929,000 | -77,091,000 | -118,882,000 | -138,058,000 | -159,584,000 | -176,987,000 | -221,450,000 | -162,023,000 | -171,664,000 | -300,541,000 | -415,302,000 | -203,335,000 | -67,009,000 | -82,373,000 | -96,108,000 | -35,660,000 | -33,820,000 | -68,194,000 | -49,316,000 | -40,925,000 | -32,702,000 | -36,528,000 | -22,989,000 | -28,411,000 | -31,419,000 | -35,491,000 | -37,710,000 | -38,284,000 | -45,137,000 | -47,885,000 | -40,420,000 | -43,270,000 | -39,366,000 | -36,012,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
yoy | -91.82% | -10.01% | 1191.77% | -675.31% | -65.87% | 38.40% | -42.93% | -104.96% | -51.79% | -56.44% | -46.32% | -14.79% | -7.04% | -41.11% | -46.68% | -20.32% | 156.18% | 264.85% | 332.12% | 470.20% | 98.13% | 20.79% | 94.88% | -12.86% | 3.42% | 86.69% | 114.52% | 44.05% | 4.08% | 2.92% | -39.04% | -25.79% | -30.39% | -25.88% | -6.70% | -11.52% | 14.66% | 32.97% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | -97.76% | -89.04% | 2124.07% | 50.07% | -75.39% | 57.27% | -1090.52% | -108.90% | -0.21% | -35.15% | -13.89% | -13.49% | -9.83% | -20.08% | 36.68% | -5.62% | -42.88% | -27.63% | 104.25% | 203.44% | -18.65% | -14.29% | 169.51% | 5.44% | -50.41% | 38.28% | 20.50% | 25.15% | -10.47% | 58.89% | -19.08% | -9.57% | -11.47% | -5.88% | -1.50% | -15.18% | -5.74% | 18.47% | -6.59% | 9.92% | 9.31% | |||||||||||||||||||||||||||||||||||||||||||||||||
operating margin % | -0.26% | -13.58% | -122.84% | -5.56% | -3.75% | -16.74% | -10.49% | 1.09% | -12.37% | -12.80% | -21.50% | -26.39% | -30.59% | -36.37% | -46.74% | -35.50% | -39.48% | -74.75% | -89.06% | -49.79% | -24.92% | -23.68% | -32.52% | -16.30% | -16.92% | -42.08% | 0% | 0% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment income | 11,926,000 | 4,997,000 | 9,962,000 | 11,582,000 | 11,801,000 | 6,213,000 | 25,330,000 | 2,065,000 | 4,828,000 | 490,000 | -5,635,000 | -8,584,000 | -3,719,000 | -1,487,000 | 1,254,000 | -4,093,000 | 3,429,000 | 31,188,000 | 1,365,000 | 2,523,000 | 2,912,000 | 97,000 | 3,113,000 | 9,093,000 | 7,669,000 | 6,655,000 | 6,321,000 | 6,292,000 | 4,917,000 | 3,673,000 | 1,320,000 | 1,334,000 | 683,000 | 595,000 | 592,000 | 535,000 | 425,000 | 466,000 | 491,000 | 365,000 | 193,000 | 222,000 | 150,000 | 160,000 | 146,000 | 86,000 | 103,000 | 55,000 | 62,000 | 67,000 | 59,000 | |||||||||||||||||||||||||||||||||||||||
interest income | -9,835,000 | 111,000 | -7,943,000 | 4,107,000 | -40,250 | -54,000 | -53,000 | 14,000 | -40,000 | 107,000 | 62,000 | 75,000 | 22,000 | 29,000 | 14,000 | 7,000 | 35,000 | 49,000 | 34,000 | 36,000 | 64,000 | 124,000 | 210,000 | 238,000 | 259,000 | 301,000 | 320,000 | 313,000 | 318,000 | -795,886 | 290,000 | 261,000 | 246,000 | 177,000 | 172,000 | 118,000 | 103,000 | 126,000 | 167,000 | 189,499.5 | 251,312 | 231,455 | 275,231 | 231,455 | 550,127.5 | 623,128 | 799,725 | |||||||||||||||||||||||||||||||||||||||||||
total other income | 2,091,000 | -4,981,000 | 385,000 | 1,975,000 | 11,912,000 | -1,730,000 | 17,465,000 | -5,806,000 | -2,990,000 | 4,597,000 | -11,045,000 | -13,819,000 | -8,230,000 | -5,965,000 | -3,404,000 | -8,773,000 | -1,223,000 | 26,572,000 | -22,971,000 | -21,059,000 | -20,000,000 | -25,056,000 | -10,575,000 | -4,116,000 | -5,043,000 | -15,335,000 | -4,651,000 | -4,412,000 | -3,686,000 | -2,837,000 | 1,269,000 | 1,283,000 | 629,000 | 545,000 | 540,000 | 481,000 | 372,000 | 412,000 | 429,000 | 325,000 | 300,000 | 211,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income before tax | -57,000 | -100,991,000 | -875,966,000 | -37,428,000 | -14,345,000 | -108,422,000 | -50,376,000 | 1,043,000 | -79,919,000 | -72,494,000 | -129,927,000 | -151,877,000 | -167,814,000 | -182,952,000 | -224,854,000 | -170,796,000 | -172,887,000 | -273,969,000 | -438,273,000 | -224,394,000 | -87,009,000 | -107,429,000 | -106,683,000 | -39,776,000 | -38,863,000 | -83,529,000 | -53,967,000 | -45,337,000 | -36,388,000 | -39,365,000 | -21,720,000 | -27,128,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax expense | -1,128,000 | -224,000 | -1,019,250 | -808,000 | -1,463,000 | -1,806,000 | -59,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | -1,185,000 | -101,215,000 | -864,585,000 | -38,236,000 | -15,808,000 | -110,228,000 | -49,766,000 | 794,000 | -81,026,000 | -74,151,000 | -127,745,000 | -148,761,000 | -166,063,000 | -180,937,000 | -220,611,000 | -166,938,000 | -176,912,000 | -31,164,000 | -436,810,000 | -219,884,000 | -86,142,000 | -105,697,000 | 77,945,000 | -40,459,000 | -38,420,000 | -83,059,000 | -53,974,000 | -45,364,000 | -36,387,000 | -39,424,000 | -21,764,000 | -26,897,000 | -30,790,000 | -34,946,000 | -37,170,000 | -37,803,000 | -44,765,000 | -47,473,000 | -39,991,000 | -42,945,000 | -39,066,000 | -35,801,000 | -32,444,000 | -32,060,000 | -19,437,000 | -16,107,000 | -11,160,000 | -12,314,000 | -10,854,000 | -12,952,000 | -14,836,000 | -10,645,000 | -7,773,000 | -6,625,000 | -4,373,000 | -3,382,000 | -2,477,000 | -2,124,000 | -1,041,000 | -2,394,000 | -3,839,000 | -3,014,000 | -2,100,000 | -2,518,000 | -4,195,000 | -1,825,000 | -1,920,000 | -2,423,000 | -3,083,000 | -3,246,000 | -4,163,000 | 11,810,480 | -3,289,000 | -3,951,000 | -4,585,000 | -4,403,000 | -4,279,000 | -5,291,000 | -6,862,000 | -7,884,000 | -7,883,000 | -5,718,584.5 | -7,413,676 | -7,874,777 | -7,585,885 | -7,874,777 | -4,210,130.25 | -5,729,378 | -5,710,984 | |
yoy | -92.50% | -8.18% | 1637.30% | -4915.62% | -80.49% | 48.65% | -61.04% | -100.53% | -51.21% | -59.02% | -42.09% | -10.89% | -6.13% | 480.60% | -49.49% | -24.08% | 105.37% | -70.52% | -660.41% | 443.47% | 124.21% | 27.26% | -244.41% | -10.81% | 5.59% | 110.68% | 148.00% | 68.66% | 18.18% | 12.81% | -41.45% | -28.85% | -31.22% | -26.39% | -7.05% | -11.97% | 14.59% | 32.60% | 23.26% | 33.95% | 100.99% | 122.27% | 190.72% | 160.35% | 79.08% | 24.36% | -24.78% | 15.68% | 39.64% | 95.50% | 239.26% | 214.75% | 213.81% | 211.91% | 320.08% | 41.27% | -35.48% | -29.53% | -50.43% | -4.92% | -8.49% | 65.15% | 9.38% | 3.92% | 36.07% | -43.78% | -53.88% | -120.52% | -6.26% | -17.84% | -9.20% | -368.24% | -23.14% | -25.33% | -33.18% | -44.15% | -45.72% | -7.48% | -7.44% | 0.12% | 3.92% | -27.38% | 76.09% | 37.45% | 32.83% | |||||
qoq | -98.83% | -88.29% | 2161.18% | 141.88% | -85.66% | 121.49% | -6367.76% | -100.98% | 9.27% | -41.95% | -14.13% | -10.42% | -8.22% | -17.98% | 32.15% | -5.64% | 467.68% | -92.87% | 98.65% | 155.26% | -18.50% | -235.60% | -292.65% | 5.31% | -53.74% | 53.89% | 18.98% | 24.67% | -7.70% | 81.14% | -19.08% | -12.64% | -11.89% | -5.98% | -1.67% | -15.55% | -5.70% | 18.71% | -6.88% | 9.93% | 9.12% | 10.35% | 1.20% | 64.94% | 20.67% | 44.33% | -9.37% | 13.45% | -16.20% | -12.70% | 39.37% | 36.95% | 17.33% | 51.50% | 29.30% | 36.54% | 16.62% | 104.03% | -56.52% | -37.64% | 27.37% | 43.52% | -16.60% | -39.98% | 129.86% | -4.95% | -20.76% | -21.41% | -5.02% | -22.03% | -135.25% | -459.09% | -16.76% | -13.83% | 4.13% | 2.90% | -19.13% | -22.89% | -12.96% | 0.01% | 37.85% | -22.86% | -5.86% | 3.81% | -3.67% | 87.04% | -26.52% | 0.32% | ||
net income margin % | -0.15% | -14.32% | -121.19% | -5.40% | -2.26% | -17.29% | -7.69% | 0.13% | -13.02% | -12.31% | -23.10% | -28.44% | -31.83% | -37.19% | -46.56% | -36.58% | -40.69% | -7.75% | -93.67% | -53.85% | -32.04% | -30.39% | 26.37% | -18.49% | -19.22% | -51.26% | -1941.87% | -1932.11% | -4680.64% | -1810.51% | -19708.62% | -19319.22% | -19708.62% | -128661.63% | -43772.47% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.01 | -0.54 | -4.7 | -0.21 | -0.09 | -0.6 | -0.27 | 0 | -0.45 | -0.42 | -0.72 | -0.84 | -0.94 | -1.04 | -1.29 | -0.97 | -1.03 | -0.18 | -2.85 | -1.46 | -0.58 | -0.71 | 0.62 | -0.31 | -0.3 | -0.66 | -0.44 | -0.37 | -0.3 | -0.33 | -0.18 | -0.23 | -0.27 | -0.32 | -0.33 | -0.36 | -0.46 | -0.49 | -0.41 | -0.45 | -0.44 | -0.4 | -0.39 | -0.39 | -0.24 | -0.23 | -0.16 | -0.19 | -0.17 | -0.21 | -0.26 | -0.19 | -0.15 | -0.13 | -0.08 | -0.08 | -0.06 | -0.06 | -0.03 | -0.08 | -0.13 | -0.11 | -0.08 | -0.09 | -0.16 | -0.07 | -0.07 | -0.09 | -0.12 | -0.12 | -0.16 | -0.1 | -0.13 | -0.15 | -0.17 | -0.17 | -0.16 | -0.36 | -0.42 | -0.42 | ||||||||||
weighted-average common shares outstanding—basic and diluted | 188,902 | 186,813 | 184,197 | 184,313 | 182,350 | 180,144 | 180,204 | 178,574 | 176,351 | 176,997 | 176,364 | 174,417 | 171,348 | 171,978 | 171,494 | 169,434 | 151,137 | 150,155 | 149,727 | 148,151 | 131,257 | 129,567 | 129,182 | 126,248 | 122,207 | 122,671 | 122,129 | 121,016 | 115,684 | 119,215 | 112,847 | 110,582 | 102,335 | 104,807 | 97,902 | 97,246 | 92,135 | 94,444 | 88,919 | 88,662 | 80,232 | 82,941 | 82,048 | 70,987 | 64,699 | 63,836 | 60,531 | 57,037 | 56,718 | 52,443 | 52,010 | 51,930 | 39,067 | 35,607 | 30,230 | 27,233 | 27,175 | 27,145 | 27,017 | 26,880 | 26,790 | 26,509 | 26,562 | 26,402 | 26,376 | 26,270 | 26,291 | 26,251 | 26,203 | |||||||||||||||||||||
interest expense | -9,978,000 | -9,577,000 | -9,607,000 | -7,865,000 | -7,871,000 | -7,818,000 | -5,410,000 | -5,235,000 | -4,511,000 | -4,478,000 | -4,658,000 | -4,680,000 | -4,652,000 | -4,616,000 | -24,336,000 | -23,582,000 | -22,912,000 | -25,153,000 | -13,688,000 | -13,209,000 | -12,712,000 | -21,990,000 | -10,972,000 | -10,704,000 | -8,603,000 | -6,510,000 | -51,000 | -51,000 | -54,000 | -50,000 | -54,000 | -11,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of acquired intangible assets | 17,764,250 | 24,435,000 | 23,311,000 | 23,311,000 | 23,311,000 | 22,992,000 | 22,929,000 | 22,928,000 | 22,914,000 | 23,526,000 | 26,356,000 | 24,654,000 | 24,047,000 | 23,940,000 | 23,824,000 | 23,190,000 | 23,199,000 | 23,430,000 | 23,430,000 | 23,339,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-lived assets | 7,824,000 | 18,698,000 | 8,152,000 | 4,446,000 | 552,000 | 69,000 | 3,432,000 | 5,946,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding—basic | 184,795 | 180,649 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding—diluted | 184,795 | 184,075 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | 610,000 | -249,000 | -1,107,000 | -1,657,000 | 2,182,000 | 3,116,000 | 1,751,000 | 2,015,000 | 4,243,000 | 3,858,000 | -4,025,000 | 242,805,000 | 1,463,000 | 4,510,000 | 867,000 | 1,732,000 | 184,628,000 | -683,000 | 443,000 | 470,000 | -7,000 | -27,000 | 1,000 | -44,000 | 231,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible asset impairment charge | 6,591,000 | 20,210,000 | 209,666,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin | 108,286,000 | 166,046,000 | 148,307,000 | 118,791,000 | 104,821,000 | 88,271,000 | 76,006,000 | 67,382,000 | 63,911,000 | 51,845,000 | 39,655,000 | 31,382,000 | 21,376,000 | 15,941,000 | 11,088,000 | 5,776,000 | 6,753,000 | 5,104,000 | 3,025,000 | 54,000 | 406,000 | 38,051 | 38,894 | 38,051 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
laboratory service revenue | 77,870,250 | 118,291,000 | 102,894,000 | 90,296,000 | 87,406,000 | 72,574,000 | 57,646,000 | 48,363,000 | 35,241,000 | 28,115,000 | 21,185,000 | 14,835,000 | 14,420,000 | 12,632,000 | 8,119,000 | 4,266,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
license fees | 294,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,035,000 | 1,036,000 | 1,036,000 | 1,351,000 | 1,307,000 | 1,287,000 | 1,247,000 | 1,247,000 | 993,000 | 337,000 | 338,000 | 338,000 | 338,000 | 1,091,000 | 1,091,000 | 1,090,000 | 1,091,000 | 1,091,000 | 1,091,000 | -2,733,172 | 1,111,000 | 498,000 | 1,128,000 | 1,128,000 | 1,129,000 | 1,128,000 | 905,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenue | 14,420,000 | 12,632,000 | 8,119,000 | 4,266,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted average common shares outstanding—basic and diluted | 70,559 | 40,155 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
product royalty fees | 4,000 | 6,000 | 4,000 | 5,000 | 7,000 | 12,000 | 9,000 | 11,000 | 7,000 | -1,000,000 | -495,000 | -292,000 | -239,000 | 19,000 | 26,000 | 17,000 | 40,000 | 61,000 | 61,000 | -164,794 | 51,000 | 46,000 | 68,000 | 41,000 | 35,000 | 22,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenue: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring | 539,000 | 788,000 | 33,000 | -625,374 | 626,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
product | 11,000 | 5,000 | 14,000 | 5,000 | 53,000 | 73,000 | 24,000 | 69,000 | 42,000 | -162,784 | 33,000 | 79,000 | 51,000 | 92,000 | 58,000 | 27,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding - basic and diluted | 34,932 | 31,283 | 26,138 | 22,949 | 18,808 | 18,550,699 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash stock-based compensation expense included in these amounts are as follows: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash stock-based compensation expense | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
included in these amounts are as follows: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total | 709 | 68.5 | -81 | 329 | 330 | 544,052 | 544,052 | 743,138.5 | 865,887 | 1,054,731 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | -273,495 | 52,000 | 303,000 | 154,000 | 120,000 | 126,000 | 329,000 | 330,000 | 328,000 | 413,930.75 | 543,870 | 567,801 | 544,052 | 743,138.5 | 865,887 | 1,054,731 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
the following summarizes the departmental allocation of stock-based compensation: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenues: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
selling, general and administrative | 2,946,000 | 2,853,000 | 3,294,000 | 3,229,000 | 3,494,000 | 3,114,000 | 1,804,892.75 | 2,395,733 | 2,534,409 | 2,289,429 | 2,534,409 | 1,788,544 | 1,964,695 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding – basic and diluted | 26,081 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
product revenue | 13,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of product revenues | 13,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | 19,024 | 18,801 | 18,165,019 | 17,886,920 | 17,817,844 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenues | 3,000 | 1,608.75 | 4,158 | 1,905 | 372 | 1,905 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | -0.01 | -0.54 | -4.7 | -0.21 | -0.09 | -0.6 | -0.27 | 0 | -0.45 | -0.42 | -0.72 | -0.84 | -0.94 | -1.04 | -1.29 | -0.97 | -1.03 | -0.18 | -2.85 | -1.46 | -0.58 | -0.71 | 0.62 | -0.31 | -0.3 | -0.66 | -0.44 | -0.37 | -0.3 | -0.33 | -0.18 | -0.23 | -0.27 | -0.32 | -0.33 | -0.36 | -0.46 | -0.49 | -0.41 | -0.45 | -0.44 | -0.4 | -0.39 | -0.39 | -0.24 | -0.23 | -0.16 | -0.19 | -0.17 | -0.21 | -0.26 | -0.19 | -0.15 | -0.13 | -0.08 | -0.08 | -0.06 | -0.06 | -0.03 | -0.08 | -0.13 | -0.11 | -0.08 | -0.09 | -0.16 | -0.07 | -0.07 | -0.09 | -0.12 | -0.12 | -0.16 | -0.1 | -0.13 | -0.15 | -0.17 | -0.17 | -0.16 | -0.36 | -0.42 | -0.42 | ||||||||||
basic and diluted | -0.313 | -0.4 | -0.42 | -0.43 | -0.263 | -0.32 | -0.32 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | 544,052 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | -0.43 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted average common shares | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
outstanding - basic and diluted | 18,376,369 | 18,376,369 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
the following summarizes the departmental allocation of stock-based compensation: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
pro forma basic and diluted | -0.2 | -0.27 | -0.26 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
excludes non-cash stock-based compensation. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assumes conversion of all outstanding shares of preferred stock into common stock effective january 1, 2001. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assumes conversion of all outstanding shares of preferred stock into common stock. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities; | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in patent costs and other assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury shares | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of common stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of convertible preferred stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of common stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of stock subscription receivable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of period | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of restricted stock through issuance of notes receivable |
We provide you with 20 years income statements for Exact Sciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Exact Sciences stock. Explore the full financial landscape of Exact Sciences stock with our expertly curated income statements.
The information provided in this report about Exact Sciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.